Clin2
NCT07486115Likely a fitRecruiting

Testing safety of BI 3814916 in healthy volunteers

Healthy

This trial tests how safe and tolerable different doses of the study drug BI 3814916 are in healthy adults. It helps find the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
136 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • Your body mass index (BMI) is between 18.5 and 30.
  • You agree not to do intense exercise for 3 days before study visits.
  • You avoid alcohol and soft drugs (like marijuana) for 2 days before visits.
  • You are generally healthy without major medical conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06575400Recruiting· Phase 1
Testing tolerance of BI 3804379 in healthy people and MASH patients

This study tests how well different doses of a new drug (BI 3804379) are tolerated. It is for healthy people and for patients with MASH (a type of fatty liver disease) who have advanced liver scarring.

Edegem
NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07486102Recruiting· Phase 1
Study of BI 3000202 in people with and without liver problems

This study tests how a new medicine, BI 3000202, is absorbed into the blood. It includes people with different levels of liver function (normal, mild, moderate, or severe) to see if liver problems affect how the medicine works.

San Antonio, Texas
NCT07837648Not yet recruiting· Phase 1
How the body absorbs a study drug given two ways

This study in healthy volunteers looks at how much of the drug BI 3034701 enters the bloodstream when given in two different ways. It helps find the best way to deliver the drug for future studies.

NCT07120425Recruiting· Phase 1
Testing IBI3032 in healthy volunteers

This study tests a new drug called IBI3032 in healthy volunteers to see how safe it is and how the body processes it. If you are in good health, you may be able to join.

Lenexa, Kansas
NCT07023354Recruiting· Phase 1
Study of BI 1291583 in people with and without liver problems

This trial tests how a new medicine, BI 1291583, enters the blood in people who have different levels of liver function (from normal to mild, moderate, or severe liver problems). It helps doctors understand if the dose needs to be adjusted for liver health.

Rialto, California

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.